logbook_erin
TL3 Regular · Halifax, CA
Keeps a very thorough log and shares the template. Weight, waist, protein, steps, sleep, side-effect scores.
Joined 8 October 2024 · last posted 17h · groups: wiki-editors, newcomer-guides
153 posts, newest first. Showing up to 150.
-
Reporting a good result: why nobody bothers and why they should Replied, post #3 · Sourcing › Vendor reports · 27 Jul 2026 · 0 likes Where I part company with the opening post, and it is a narrow parting. Blind submission is worth the effort: have someone else relabel the sample so neither you nor…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #52 · Clinical › Prescriber conversations · 26 Jul 2026 · 28 likes A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is a legitimate question.
-
Pooling trials with different estimands Replied, post #128 · Evidence › Meta-analyses · 25 Jul 2026 · 1 like This follows post #125 rather than contradicting it. I changed my mind about pooling trials with different estimands after someone here asked me for the source and I…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #100 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 0 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population.
-
Follow-up: UK access routes, dated and sourced Replied, post #14 · Regional › UK & Ireland · 23 Jul 2026 · 30 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Immortal time bias in a claims-database study — one year on Replied, post #38 · Evidence › Study critique · 22 Jul 2026 · 5 likes Narrowing post #35, because the general version has more than one answer. Since Immortal time bias keeps coming up, it should probably be a maintained page rather than…
-
A site rotation scheme that is easy enough to actually follow Replied, post #119 · Practice › Administration · 19 Jul 2026 · 6 likes Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
-
Seven-day rolling means and why weekly readings mislead Replied, post #58 · Outcomes › Progress reports · 19 Jul 2026 · 9 likes I read post #56 twice before replying, because I had assumed the opposite. Rate of change matters more than the absolute number for most of the questions people ask…
-
The headache that turns out to be dehydration — the long version Replied, post #69 · Nutrition & Training › Hydration & electrolytes · 18 Jul 2026 · 32 likes Post #67 answers the question as asked. The question underneath it is different. The confident answers on headache and the well-sourced answers are not the same…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #14 · Analytics › Impurities & related substances · 17 Jul 2026 · 6 likes Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute depends on the hydrophobicity of the residue that is missing, so…
-
Programming during a large energy deficit Replied, post #41 · Nutrition & Training › Resistance training · 16 Jul 2026 · 31 likes A resistance stimulus during a deficit is the other half of the lean-tissue argument, and the evidence for it is reasonably strong.
-
Why the timeline is on the right and not the left — what changed since Replied, post #74 · Meta › Site feedback · 14 Jul 2026 · 12 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #65 · Evidence › Journal club · 13 Jul 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #97 · Evidence › Journal club · 11 Jul 2026 · 0 likes Adding the measurement that post #96 says would settle it. Practical answer on SURMOUNT-OSA, since the theoretical one is upthread: do the simplest check first, write…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #41 · Analytics › Home & field testing · 30 Jun 2026 · 0 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
How this community escalates rather than diagnoses — does this still hold? Replied, post #5 · Safety › Adverse events · 29 Jun 2026 · 9 likes Research-use-only material carries no safety surveillance of any kind, which is a reason for more caution rather than less.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #28 · Analytics › Impurities & related substances · 27 Jun 2026 · 10 likes Post #27 is right about the mechanism and I think understates the practical bit. Peptide impurities that differ by a single residue are the hardest to resolve and the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #97 · Practice › Administration · 24 Jun 2026 · 3 likes Site reactions that appear immediately and settle within a day are described commonly here. Ones that appear a day later and spread are a different observation and…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #18 · Evidence › Meta-analyses · 22 Jun 2026 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. I have kept the units…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #121 · Practice › Reconstitution · 21 Jun 2026 · 13 likes Coming back to post #119, because the follow-up matters more than the original answer. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #50 · Start Here › How to Ask · 18 Jun 2026 · 25 likes Where I part company with post #46, and it is a narrow parting. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which…
-
Revisiting: What pooling buys you and what it destroys Replied, post #58 · Evidence › Meta-analyses · 17 Jun 2026 · 3 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. I would rather say I…
-
Constipation management, with a dietitian's contribution Replied, post #79 · Practice › Side effects · 15 Jun 2026 · 29 likes I had written a reply contradicting post #75 and deleted it. Here is what survived. Constipation is reported at least as often as nausea and is discussed a fraction as…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #21 · Compounds › Secretagogues & GH axis · 11 Jun 2026 · 4 likes The most useful thing anyone has posted about GHRH analogues versus ghrelin mimetics in this category was a table of what had been measured and by whom. That is what I…
-
Injecting into an area that has become firm: why not to Replied, post #5 · Practice › Administration · 2 Jun 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. That…
-
What to include when your question involves a chromatogram — one year on Replied, post #22 · Start Here › How to Ask · 1 Jun 2026 · 27 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it. The…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #42 · Wellbeing › Sleep · 24 May 2026 · 0 likes Coming back to post #40, because the follow-up matters more than the original answer. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic…
-
Currency conversion and the cost you did not see Replied, post #3 · Sourcing › Payments · 20 May 2026 · 25 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #68 · Compounds › Tirzepatide · 19 May 2026 · 1 like Post #65 is the version of this I will quote in future. One addition. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time.…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #10 · Analytics › COA interpretation · 29 Apr 2026 · 1 like Second-hand on field-by-field walk through a certificate, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #50 · Practice › Interactions · 28 Apr 2026 · 0 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. Where a published interaction study exists it usually reports an area-under-curve…
-
Preservatives: function, testing, and limits — one year on Replied, post #12 · Pharmacology › Formulation chemistry · 24 Apr 2026 · 24 likes Post #11 answers the question as asked. The question underneath it is different. Preservatives has been discussed here with more heat than it deserves, mostly because…
-
What a certificate commits its issuer to — the long version Replied, post #2 · Analytics › COA interpretation · 19 Apr 2026 · 12 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
The most useful thing you learned here that was not the answer you came for Replied, post #35 · Lounge › Off topic · 16 Apr 2026 · 3 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #47 · Practice › Administration · 14 Apr 2026 · 7 likes Post #45 describes the usual case. This is about the unusual one. The question underneath Rotating between abdomen is usually "how would I tell?" rather than "what is…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #88 · Practice › Reconstitution · 5 Apr 2026 · 27 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #6 · Compounds › Oral incretins · 2 Apr 2026 · 6 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #78 · Pharmacology › Pharmacokinetics · 21 Mar 2026 · 0 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #32 · Practice › Administration · 17 Mar 2026 · 0 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first. Two…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #70 · Research Methods › N-of-1 designs · 16 Mar 2026 · 3 likes A rolling mean over several days is far more informative than any single reading for anything that varies day to day, which is nearly everything. Written in the hope of…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #51 · Lounge › Introductions · 13 Mar 2026 · 22 likes Hello. Fair warning that this place will change how you read a certificate, and that you will not be able to go back to accepting one at face value. I have written this…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #14 · Meta › Announcements · 9 Mar 2026 · 6 likes Taking post #11 at face value and following it one step further. The useful distinction on Trust level 3 requirements is between what was measured and what was inferred…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #20 · Compounds › Repair & healing peptides · 9 Mar 2026 · 30 likes I would keep Reading a preclinical wound-healing model and the decision it usually gets used for separate in this thread. They are related and they are not the same…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #59 · Practice › Interactions · 2 Mar 2026 · 28 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #31 · Practice › Administration · 26 Feb 2026 · 23 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Coming back to: Time to steady state after a dose increase Replied, post #6 · Pharmacology › Pharmacokinetics · 26 Feb 2026 · 19 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #115 · Practice › Dosing & titration · 21 Feb 2026 · 10 likes Post #113 and I disagree about the size of the effect, not about the direction. Reaching a dose and staying there for a year: the question of whether a stable dose…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #25 · Practice › Interactions · 18 Feb 2026 · 0 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #19 · Clinical › Comorbidities · 15 Feb 2026 · 28 likes Narrowing post #16, because the general version has more than one answer. The bit of gastro-oesophageal reflux that nobody enjoys is that the answer changes depending…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #27 · Compounds › Semaglutide · 14 Feb 2026 · 1 like The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Revisiting: Absolute versus relative contraindications Replied, post #15 · Safety › Contraindications · 13 Feb 2026 · 33 likes Agreed on all of that, and I have nothing to add to it.
-
Trifluoroacetate content and its consequences Replied, post #113 · Analytics › Impurities & related substances · 9 Feb 2026 · 0 likes I have three months of notes on trifluoroacetate content and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #76 · Pharmacology › Pharmacokinetics · 5 Feb 2026 · 0 likes Before the thread moves on from Half-life — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Personal import allowances, compared — a second dataset Replied, post #62 · Access › International · 2 Feb 2026 · 1 like That matches what I have seen, for whatever a single anecdote is worth.
-
Trifluoroacetate content and its consequences Replied, post #46 · Analytics › Impurities & related substances · 30 Jan 2026 · 11 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
-
Revisiting: Absolute versus relative contraindications Replied, post #14 · Safety › Contraindications · 26 Jan 2026 · 1 like Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Guidelines revision: what changed and why — one year on Replied, post #62 · Meta › Announcements · 24 Jan 2026 · 1 like When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here. That…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #9 · Outcomes › Body composition · 20 Jan 2026 · 0 likes Narrowing post #8, because the general version has more than one answer. Ultrasound and skinfolds is one of those subjects where the general answer and the answer for a…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #61 · Pharmacology › Pharmacokinetics · 16 Jan 2026 · 31 likes The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after several doses is roughly double the…
-
A partial dose because the pen emptied mid-injection Replied, post #91 · Practice › Administration · 10 Jan 2026 · 26 likes Partial dose because the pen has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #36 · Compounds › Tirzepatide · 7 Jan 2026 · 1 like Post #33 and I disagree about the size of the effect, not about the direction. Injection-site reactions were reported at a low but non-zero rate across the trials. The…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #23 · Documentation › Wiki requests · 4 Jan 2026 · 10 likes Answering the question post #21 raises rather than the one it answers. Scope creep: if you think a page is attempting too much and should be split into multiple pages,…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #81 · Compounds › Oral incretins · 1 Jan 2026 · 11 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #6 · marked as the solution · Practice › Side effects · 26 Dec 2025 · 19 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Early satiety becoming a problem rather than a benefit Replied, post #18 · Practice › Side effects · 22 Dec 2025 · 11 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Prescription requirements and telehealth models Replied, post #83 · Sourcing › Regulatory · 22 Dec 2025 · 0 likes Everything in post #80 holds. The case it does not cover is the one I have. Two things can be true about prescription requirements and telehealth models at once: the…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #3 · Practice › Storage & stability · 21 Dec 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Coming back to: Pen dose counters: what a click does and does not guarantee Replied, post #2 · Devices › Pens & autoinjectors · 19 Dec 2025 · 26 likes Building on the opening post rather than restating it. A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #7 · Research Methods › N-of-1 designs · 1 Dec 2025 · 25 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #23 · Research Methods › N-of-1 designs · 29 Nov 2025 · 5 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. Filing this under things…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #25 · Access › Pricing · 28 Nov 2025 · 5 likes Answering the question post #21 raises rather than the one it answers. Answering the Price changes question as asked, then the question I think is meant. As asked: yes,…
-
Sleep quality changes during weight loss — what changed since Replied, post #64 · Wellbeing › Sleep · 15 Nov 2025 · 4 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
What pooling buys you and what it destroys Replied, post #66 · Evidence › Meta-analyses · 14 Nov 2025 · 0 likes Post #63 is the version of this I will quote in future. One addition. On pooling buys: the maintained page in the documentation commons covers the general case with…
-
Batch date after test date, and other internal inconsistencies Replied, post #16 · Analytics › COA interpretation · 10 Nov 2025 · 1 like The signature block matters more than it appears to. A named individual with a date is a different kind of document from an unsigned one, whatever the numbers say. On…
-
Reading SURMOUNT-1 without the press release Replied, post #55 · Compounds › Tirzepatide · 4 Nov 2025 · 9 likes Where the reading SURMOUNT-1 without the press reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #12 · Devices › Pens & autoinjectors · 2 Nov 2025 · 0 likes An update on my earlier Pen mechanics post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Search filters: what is missing Started this topic · Meta › Site feedback · 30 Oct 2025 · 0 likes Search filters: what is missing — setting out what I have, and where I think it stops being reliable. Search filters — I have the observation and I do not trust my…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #40 · Analytics › Home & field testing · 27 Oct 2025 · 6 likes Post #37 is the version of this I will quote in future. One addition. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
Sleep tracking data and its considerable limitations Replied, post #39 · Wellbeing › Sleep · 20 Oct 2025 · 18 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher. This is…
-
Reading an interaction checker output critically Replied, post #19 · Practice › Interactions · 10 Oct 2025 · 4 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Follow-up: Why appetite effects are mostly central Replied, post #59 · Pharmacology › Receptor biology · 6 Oct 2025 · 3 likes Everything in post #55 holds. The case it does not cover is the one I have. Central versus peripheral action: GLP-1 agonism works through both central nervous system…
-
Reading SURMOUNT-1 without the press release Replied, post #24 · Compounds › Tirzepatide · 4 Oct 2025 · 2 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #57 · Compounds › Other compounds · 28 Sep 2025 · 18 likes I had written a reply contradicting post #55 and deleted it. Here is what survived. The honest summary for most of this subcategory: a plausible mechanism, animal data,…
-
Second pass at: Programming during a large energy deficit Replied, post #9 · Nutrition & Training › Resistance training · 16 Sep 2025 · 1 like Machine-based work is often better tolerated when energy is low and is not inferior for this purpose.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #102 · Compounds › Oral incretins · 15 Sep 2025 · 2 likes Confirming post #99 from a second method, which matters more than confirming it from a second person. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #42 · Compounds › Repair & healing peptides · 12 Sep 2025 · 10 likes Practical note on BPC-157: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #94 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Aggregated purity results across four: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look,…
-
Reading SURMOUNT-1 without the press release Replied, post #4 · Compounds › Tirzepatide · 7 Sep 2025 · 20 likes Helpful, and short, which on this subject is harder than long.
-
Hypertension improvement and when medication needs revisiting Replied, post #35 · Clinical › Comorbidities · 1 Sep 2025 · 18 likes Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst. If this…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Started this topic · Compounds › Tirzepatide · 29 Aug 2025 · 0 likes Asking directly, because I could not find a straight answer: Tirzepatide and nausea: is the profile genuinely different or just differently reported? Asking about…
-
What this community means by "a source", in practical terms Replied, post #90 · Start Here › Welcome · 29 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
When to stop reading forums, including this one Replied, post #19 · Wellbeing › Mental health · 27 Aug 2025 · 0 likes Taking post #18 at face value and following it one step further. Expectations set by other people's reported trajectories are a documented source of distress, and the…
-
When a preprint is the best available evidence and we say so Replied, post #61 · Evidence › Preprints · 16 Aug 2025 · 10 likes I would keep preprint and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
A ten-fold dose error caught before injection — one year on Replied, post #129 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Ten-fold dose error caught: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
-
How to research a compound with no human data without deceiving yourself Replied, post #100 · Compounds › Other compounds · 4 Aug 2025 · 0 likes Second-hand on research a compound, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
A newcomer's list of things that confused me, and the fixes Replied, post #14 · Start Here › Welcome · 15 Jul 2025 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Sodium, potassium and magnesium when intake drops Replied, post #60 · Nutrition & Training › Hydration & electrolytes · 15 Jul 2025 · 2 likes This follows post #59 rather than contradicting it. Trying to state the sodium position in a way that someone who disagrees would recognise as fair, because I do not…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #50 · Data & Tools › Calculators · 13 Jul 2025 · 6 likes This follows post #49 rather than contradicting it. Posting my titration planner refuses numbers with the method attached so they can be discounted properly.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #149 · Practice › Reconstitution · 29 Jun 2025 · 32 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Why the timeline is on the right and not the left Replied, post #33 · Meta › Site feedback · 25 Jun 2025 · 2 likes Careful with the language on timeline. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Sequence verification for an obscure compound: how it is done Replied, post #68 · Compounds › Other compounds · 20 Jun 2025 · 0 likes Sequence verification: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #31 · Compounds › Semaglutide · 17 Jun 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #21 · Sourcing › Regulatory · 9 Jun 2025 · 33 likes The reason compound being unapproved keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
Counter-ion content and its effect on measured mass Replied, post #56 · Analytics › Mass spectrometry · 4 Jun 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Regression to the mean in progress reports Replied, post #15 · Research Methods › Statistics · 31 May 2025 · 6 likes Answering the question post #12 raises rather than the one it answers. I changed my mind about regression after someone here asked me for the source and I could not…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #133 · Compounds › Semaglutide · 25 May 2025 · 20 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Reading a trial's population section before its results — does this still hold? Replied, post #138 · Evidence › Trials · 23 May 2025 · 31 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Half-life, steady state, and accumulation worked through Replied, post #11 · Pharmacology › Pharmacokinetics · 22 May 2025 · 7 likes Post #10 answers the question as asked. The question underneath it is different. Area under the curve is the exposure measure that matters for most effects in this…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #39 · Regional › UK & Ireland · 22 May 2025 · 19 likes Building on post #36 rather than restating it. An observation about Pharmacy supply that I cannot explain and am posting anyway, on the principle that unexplained…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #22 · Clinical › Bloodwork · 20 May 2025 · 0 likes On post #20 — agreed on the reasoning, with one qualification. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
Travel coolers and how long they really hold — the long version Replied, post #5 · Devices › Cold chain · 19 May 2025 · 8 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw. I have…
-
EU-wide position versus national implementation Replied, post #4 · Regional › European Union · 10 May 2025 · 0 likes Narrowing the opening post, because the general version has more than one answer. A device-and-compound combination has one authorisation and two supply chains, and the…
-
Follow-up: Documentation that appears only after payment Replied, post #60 · Sourcing › Red flags · 9 May 2025 · 19 likes Documentation came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #131 · Evidence › Journal club · 23 Apr 2025 · 3 likes STEP 1 would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Telehealth prescribing models in the US Replied, post #88 · Regional › North America · 22 Apr 2025 · 22 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #18 · Evidence › Journal club · 18 Apr 2025 · 25 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Reading an MS report that only gives you a single number Replied, post #52 · Analytics › Mass spectrometry · 13 Apr 2025 · 11 likes Calibration state at the time of the run determines whether the ppm figure means anything. A report that states when the instrument was last calibrated is unusual and…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #62 · Compounds › Semaglutide · 3 Apr 2025 · 17 likes Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it is worth being precise that the enrolled population had established…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #119 · Sourcing › Regulatory · 2 Apr 2025 · 0 likes Taking post #116 at face value and following it one step further. Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #46 · Analytics › Mass spectrometry · 26 Mar 2025 · 2 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. An honest declaration on adducts: I have a prior here and it is…
-
UK access routes, dated and sourced — a second dataset Replied, post #54 · Regional › UK & Ireland · 23 Mar 2025 · 0 likes Post #53 answers the question as asked. The question underneath it is different. Regional variation in NHS: access varies dramatically by region depending on local…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #115 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #75 · Evidence › Journal club · 11 Mar 2025 · 15 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Scheduled maintenance and what will be unavailable Replied, post #66 · Meta › Announcements · 8 Mar 2025 · 11 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #47 · Compounds › Secretagogues & GH axis · 28 Feb 2025 · 26 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #122 · Evidence › Journal club · 10 Feb 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #30 · Practice › Reconstitution · 7 Feb 2025 · 4 likes Picking up post #29: that is the part I would want checked first. Worth separating reconstituting a multi-strength kit as a question about the compound from…
-
What changed in 2026, by region Replied, post #123 · Access › International · 5 Feb 2025 · 0 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. Worth…
-
What we do not know about retatrutide, listed explicitly Replied, post #82 · Compounds › Retatrutide · 4 Feb 2025 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Protein density versus volume when you cannot eat much Replied, post #48 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Canadian access and provincial variation Replied, post #19 · Regional › North America · 25 Jan 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
When to suspect the method rather than the sample Replied, post #66 · Analytics › Method validation · 15 Jan 2025 · 0 likes On post #64 — agreed on the reasoning, with one qualification. Stability-indicating method: one that can separate a compound from its degradation products. Critical for…
-
Recovery when intake is low: what to cut first Replied, post #64 · Nutrition & Training › Resistance training · 13 Jan 2025 · 18 likes Right, and stated more narrowly than I would have dared to state it.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #76 · Compounds › Semaglutide · 23 Dec 2024 · 15 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Body image changing more slowly than the body Replied, post #83 · Wellbeing › Mental health · 20 Dec 2024 · 10 likes Post #81 and I disagree about the size of the effect, not about the direction. Nobody has said the unglamorous part of body image yet, so: most of the variation is…
-
The topic list is dense — is that deliberate? Replied, post #69 · Meta › Site feedback · 19 Dec 2024 · 0 likes Reporting a real defect: on a long topic the jump-to-post link scrolls to the right post but the highlight does not fire on the first load. Second load is fine.…
-
Body image changing more slowly than the body Replied, post #68 · Wellbeing › Mental health · 18 Dec 2024 · 4 likes Post #67 answers the question as asked. The question underneath it is different. The documentation on body image is better than this thread and I say that as someone…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #156 · Analytics › COA interpretation · 18 Dec 2024 · 20 likes Nothing to add, except that this is the answer I would give if asked.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #72 · Access › Insurance & coverage · 16 Dec 2024 · 4 likes Saving this. It is the version I will quote when the question comes round again.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #70 · Compounds › Tirzepatide · 3 Dec 2024 · 18 likes That is clearer than the version I had in my head. Thank you.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #40 · Practice › Side effects · 2 Dec 2024 · 0 likes I had written a reply contradicting post #38 and deleted it. Here is what survived. Tracking severity on a simple scale with dates is far more useful than describing it…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #18 · Clinical › Special populations · 20 Nov 2024 · 0 likes Something worth flagging about Type 1 diabetes: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
EMA product information as a primary source — does this still hold? Replied, post #83 · Regional › European Union · 17 Nov 2024 · 20 likes Everything in post #81 holds. The case it does not cover is the one I have. Nothing here is medical or legal advice, and this subcategory in particular attracts…
-
EMA product information as a primary source — does this still hold? Replied, post #68 · Regional › European Union · 16 Nov 2024 · 32 likes Prescription status is harmonised at the level of the authorisation and the practical route to a prescription is not.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #25 · Access › Insurance & coverage · 13 Nov 2024 · 0 likes Adding what did not work for me on Step therapy requirements, since the failures never get written up and they are half the useful information.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #22 · Compounds › Semaglutide · 12 Nov 2024 · 0 likes Post #20 describes the usual case. This is about the unusual one. Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported on kidney…
-
Why "any advice?" is the least effective ending for a post Replied, post #11 · Start Here › How to Ask · 5 Nov 2024 · 0 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #15 · Sourcing › Regulatory · 27 Oct 2024 · 15 likes An observation about Research-use-only labelling that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
-
Why a preprint's supplementary material is often the best part Replied, post #39 · Evidence › Preprints · 26 Sep 2024 · 2 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful. Marking that as an…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #41 · Evidence › Preprints · 24 Sep 2024 · 23 likes Confirming post #40 from a second method, which matters more than confirming it from a second person. Server repositories: medRxiv for medicine, bioRxiv for biology.…